RxDoctor Payments DataLook up a doctor →

Kushagra Verma, MD

Orthopaedic Surgery of the Spine · Los Alamitos, CANPI 1568788917

Payments from drug & device makers

$288,997in general payments, 2019–2025

Across 417 payments — averaging $693.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$80K
  • Stryker$74K
  • Medical Device Business Services, Inc.$58K
  • Kyocera Medical Technologies, Inc.$40K
  • Medtronic$10K
  • Aegis Spine, Inc.$4K
  • plus $23K from 46 others
$64,254in research payments, 2019–2025

Across 13 payments — averaging $4942.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Globus Medical$64K

What the payments were for

  • Consulting fees$168,00180%
  • Speaking & faculty fees$7,0203%
  • Travel & lodging$20,16810%
  • Food & beverage$13,5066%
  • Education$2850%
  • Gifts$750%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$288,997 in reported general payments places this provider in the 80th percentile of 288 orthopaedic surgery of the spine providers in California.

See all orthopaedic surgery of the spine providers in California

Medicare billing

Part B allowed, 2024
$215,429
Medicare patients
175
Services billed
736

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin168$1,469
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen71$1,125
Cyclobenzaprine Hcl72$667
Tizanidine Hcl24$379
Ondansetron Hcl40$202
Cephalexin34$116
Methylprednisolone11$97
Tramadol Hcl15$80
Naproxen14$59

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Los Alamitos

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →